Accueil

ChangE From Any Systemic psoriasiS therapY to Raptiva (EASY)

Study Description: 
To assess the safety of transitioning subjects to Raptiva therapy from standard oral systemic or phototherapy by overlapping with Raptiva whilst tapering the initial systemic therapy or phototherapy dose.
Maladies et affections de la peau: 
Psoriasis
Study Start Date: 
janvier 2008
Estimated completion date: 
mai 2009
Study Location(s): 
Waterloo
Province: 
Ontario
Agegroup: 
18+ years
Gender: 
Both
Healthy Volunteers: 
No
Study Director/Investigator: 
Nicole Selenko-Gebauer
Pour nous joindre: 
Kim Papp 519-579-9535

Contact Information:

Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
 

Christine Jackson, Executive Director
phone: 613-422-4265
fax: 613-422- 4267
 

pageTracker._trackPageview();